Could Sars-Cov2 affect MS progression?

Published on
Journal: Multiple sclerosis and related disorders
[저자] Arianna Di Stadio, Luigina Romani, Evanthia Bernitsas
[Category] SARS,
PMC URL    Pubmed URL    [DOI] 10.1016/j.msard.2020.102540    
[Article Type] Review
[Source] pubmed

A long-term neurologic sequela arising from COVID-19 infection in multiple sclerosis (MS) patients could be related both to the increase of cytokines and the activation of NLRP3 inflammasome by the Sars-CoV2. These two mechanisms may cause a worsening of MS several months after the resolution of the infection.

All Keywords
【저자키워드】 COVID-19, microglia, inflammasomes, Long-term sequela, Sars-CoV2, Multiple sclerosis.,